BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32904358)

  • 1. An Update on Systemic Sclerosis and its Perioperative Management.
    Carr ZJ; Klick J; McDowell BJ; Charchaflieh JG; Karamchandani K
    Curr Anesthesiol Rep; 2020; 10(4):512-521. PubMed ID: 32904358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH).
    Argula RG; Ward C; Feghali-Bostwick C
    Ther Clin Risk Manag; 2019; 15():1427-1442. PubMed ID: 31853179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.
    Almaaitah S; Highland KB; Tonelli AR
    Integr Blood Press Control; 2020; 13():15-29. PubMed ID: 32280271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung transplantation in patients with scleroderma.
    De Cruz S; Ross D
    Curr Opin Rheumatol; 2013 Nov; 25(6):714-8. PubMed ID: 24061075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).
    Khedoe P; Marges E; Hiemstra P; Ninaber M; Geelhoed M
    Front Immunol; 2020; 11():1990. PubMed ID: 33013852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis. A clinical overview.
    Generini S; Fiori G; Moggi Pignone A; Matucci Cerinic M; Cagnoni M
    Adv Exp Med Biol; 1999; 455():73-83. PubMed ID: 10599326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature.
    Giuggioli D; Lumetti F; Colaci M; Fallahi P; Antonelli A; Ferri C
    Autoimmun Rev; 2015 Nov; 14(11):1072-8. PubMed ID: 26209905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Sclerosis: Current State and Survival After Lung Transplantation.
    Minalyan A; Gabrielyan L; Khanal S; Basyal B; Derk C
    Cureus; 2021 Jan; 13(1):e12797. PubMed ID: 33628666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Artery Dimensions as a Prognosticator of Transplant-Free Survival in Scleroderma Interstitial Lung Disease.
    Gleason JB; Patel KB; Hernandez F; Hadeh A; Highland KB; Rahaghi F; Mehta JP
    Lung; 2017 Aug; 195(4):403-409. PubMed ID: 28456874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging drugs and therapeutics for systemic sclerosis.
    Lee JJ; Pope JE
    Expert Opin Emerg Drugs; 2016 Dec; 21(4):421-430. PubMed ID: 27813423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleroderma epidemiology update.
    Calderon LM; Pope JE
    Curr Opin Rheumatol; 2021 Mar; 33(2):122-127. PubMed ID: 33481429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive lung fibrosis and mortality can occur in early systemic sclerosis patients without pulmonary abnormalities at baseline assessment.
    Vanaken L; Landini N; Lenaerts J; Claeys E; Lenaerts J; Wuyts WA; Verschakelen J; De Langhe E
    Clin Rheumatol; 2020 Nov; 39(11):3393-3400. PubMed ID: 32385764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary involvement in systemic sclerosis.
    Shahin AA
    Treat Respir Med; 2006; 5(6):429-36. PubMed ID: 17154672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
    Jimenez SA; Piera-Velazquez S
    Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative Complications in Patients with Systemic Sclerosis: A Comparative Cohort Analysis.
    Carr ZJ; Yan L; Yanez ND; Schonberger RB; Bohorquez M; He Z; Li F; Hines RL; Treggiari MM
    Med Res Arch; 2023 Oct; 11(10):. PubMed ID: 38037571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heart involvement in systemic sclerosis: analysis of four cases].
    Wielosz E; Borys O; Błaszczak P; Majdan M
    Ann Acad Med Stetin; 2012; 58(1):33-9; discussion 39. PubMed ID: 23547392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contemporary management of systemic sclerosis.
    Eldoma M; Pope J
    Expert Rev Clin Immunol; 2018 Jul; 14(7):573-582. PubMed ID: 29874475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perioperative management of patients with systemic scleroderma].
    Bégneu E; Aïssou M; Lescot T; Cabane JP; Beaussier M
    Ann Fr Anesth Reanim; 2014 Dec; 33(12):669-76. PubMed ID: 25447779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.